NEW YORK — Covera Health, a leading provider of analytics-based programs to reduce medical misdiagnoses and improve quality of care, has closed $8.5 million in Series A funding.
The financing was led by Equity Group Investments (EGI), the private investment firm led by Sam Zell. “EGI, with their flexible capital base and strong sense of engagement, is an ideal partner for us,” said Ron Vianu, CEO, Covera Health.
The round also included select strategic and individual investors.
Covera Health plans to use the proceeds to deepen existing clinical partnerships, invest heavily in its research and development efforts around quality analytics, as well as establish new relationships with various clinical and data partners. In addition, the Company also intends to use the capital to support several growth initiatives, accelerate product development, and further build out its data science, engineering, and sales teams.
“An accurate diagnosis is fundamentally important for formulating the right treatment plan. That is why we started in radiology. All too often, patients are misdiagnosed at this pivotal juncture in their care, hindering their ability to get better,” said Ron Vianu. “Our approach to improving outcomes is premised upon partnering with providers to better understand how to measure and deliver quality care, ensuring each and every patient has the best opportunity for recovery,” added Vianu.